Atlas Trials

Ovarian Cancer, Epithelial

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Ovarian Cancer, Epithelial

RecordFirmDate
Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer (NCT05422183)Zhongda Hospital2022-06-30
A Study of NX-1607 in Adults With Advanced Malignancies (NCT05107674)Nurix Therapeutics, Inc.2021-09-29
A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation (NCT04473339)CAI Hongbing2020-08-01
Prospective Randomized Trial of Streamlined Genetic Education and Testing for Ovarian Cancer Patients (NCT04537702)Duke University2019-08-08
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer (NCT03371693)Zhongnan Hospital2017-09-30
Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer (NCT03025477)Groupe Hospitalier Diaconesses Croix Saint-Simon2016-10-01
The Efficacy of Involved-field Radiation Therapy for Residual or Locoregionally Recurrent Epithelial Ovarian Cancer After Definitive Treatment; Multi-institutional Clinical Trial (NCT02135523)Yonsei University2014-02-06
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors (NCT01286987)Pfizer2011-01-03

Track Ovarian Cancer, Epithelial automatically

Every clearance here is in the API, with alerts when new ones post.